compounded semaglutide philadelphia Personalized NEW Apo-Semaglutide Pens Now Available

Our platform handles the administrative and quality oversight, allowing pharmacists to concentrate on safely preparing customized medications, thereby ensuring continuity of care without compromising on safety

Patients taking tirzepatide 10 mg achieved an average of 19.5% weight loss, and patients taking tirzepatide 15 mg achieved an average of 20.9% weight loss

For type 2 diabetes, treatment should continue only if there is at least 11 mmol/mol (1.0%) reduction in HbA1c and weight loss of at least 3%

Keeping to this schedule is important to keep the treatment working well

The frequency of gastrointestinal side effects is higher with retatrutide (nausea affects about 43% vs 12-33% for Mounjaro)

With proper guidance from healthcare professionals, you can use this treatment safely while minimizing any potential risks or side effects